MedPath
NMPA Approval

Insulin Lispro Injection

S20191010

August 1, 2019

H20170085

Drug Information

赖脯胰岛素注射液

优泌乐

注射剂

3ml:300单位(笔芯)

生物制品

August 1, 2019

July 31, 2024

Company Information

Applicant Company

Papendorpseweg 83,3528 BJ Utrecht,the Netherlands

Manufacturing Company

eli lilly italia s.p.a.

Via Gramsci 731-733, Sesto Fiorectino,50019,Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

赖脯胰岛素注射液 - NMPA 批准文号 | MedPath